These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16491336)

  • 1. Fluorodeoxyglucose positron emission tomography for melanoma staging: refining the indications.
    Wagner JD
    Ann Surg Oncol; 2006 Apr; 13(4):444-6. PubMed ID: 16491336
    [No Abstract]   [Full Text] [Related]  

  • 2. Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy.
    Jung JY; Roh MR; Chung HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):126-7. PubMed ID: 18181996
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography for staging and management of malignant melanoma.
    Prichard RS; Hill AD; Skehan SJ; O'Higgins NJ
    Br J Surg; 2002 Apr; 89(4):389-96. PubMed ID: 11952577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma imaging with highly specific PET probes: ready for prime time?
    Minn H; Vihinen P
    J Nucl Med; 2011 Jan; 52(1):5-7. PubMed ID: 21149485
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant melanoma: diagnostic value of F-18 FDG positron emission tomography].
    Aigner RM; Schwarz T; Richtig E
    Wien Med Wochenschr; 2002; 152(11-12):286-8. PubMed ID: 12138657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma staging using whole-body positron emission tomography.
    Paquet P; Hustinx R; Rigo P; Piérard GE
    Melanoma Res; 1998 Feb; 8(1):59-62. PubMed ID: 9508378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography/computed tomography in melanoma.
    Bourgeois AC; Chang TT; Fish LM; Bradley YC
    Radiol Clin North Am; 2013 Sep; 51(5):865-79. PubMed ID: 24010910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
    Mijnhout GS; Pijpers R; Hoekstra OS; Teule GJ; Borgstein PJ; Meijer S
    Cancer; 1999 Mar; 85(5):1199-201. PubMed ID: 10091807
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients.
    Brady MS; Akhurst T; Spanknebel K; Hilton S; Gonen M; Patel A; Larson S
    Ann Surg Oncol; 2006 Apr; 13(4):525-32. PubMed ID: 16474909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
    Basu S; Alavi A
    Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
    [No Abstract]   [Full Text] [Related]  

  • 11. Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
    Pawlik TM; Erasmus JJ; Truong MT; Macapinlac H; Ross MI; Gershenwald JE
    AJR Am J Roentgenol; 2006 Jul; 187(1):W117-9. PubMed ID: 16794124
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma metastasis to the testis demonstrated with FDG PET/CT.
    Weng LJ; Schöder H
    Clin Nucl Med; 2004 Dec; 29(12):811-2. PubMed ID: 15545888
    [No Abstract]   [Full Text] [Related]  

  • 13. New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma.
    Cobben DC; Koopal S; Tiebosch AT; Jager PL; Elsinga PH; Wobbes T; Hoekstra HJ
    Eur J Surg Oncol; 2002 Nov; 28(7):692-700. PubMed ID: 12431464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy.
    Hannah A; Feigen M; Quong G; Akhurst T; Berlangieri SU; Zimet A; Zalcberg J; McKay WJ; Scott AM
    Otolaryngol Head Neck Surg; 2000 Feb; 122(2):304-6. PubMed ID: 10652412
    [No Abstract]   [Full Text] [Related]  

  • 15. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
    Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
    Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
    Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
    Hafner J
    Dermatol Surg; 2010 Dec; 36(12):2082-3. PubMed ID: 21126282
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers.
    Annunziata S; Laudicella R; Caobelli F; Pizzuto DA; Aimn Working Group Y
    Curr Radiopharm; 2020; 13(1):6-13. PubMed ID: 31749438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients.
    Bastiaannet E; Oyen WJ; Meijer S; Hoekstra OS; Wobbes T; Jager PL; Hoekstra HJ
    Br J Surg; 2006 Feb; 93(2):243-9. PubMed ID: 16323165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body positron emission tomography: an accurate staging modality for metastatic melanoma.
    Böni R
    Arch Dermatol; 1996 Jul; 132(7):833-4. PubMed ID: 8678582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.